Directed Verdict Victory for Novartis after First Day of Jury Trial in Lamisil Case

On the first day of a jury trial, United States Magistrate Judge Bristow Marchant granted a motion for judgment as a matter of law in favor of firm client Novartis Pharmaceuticals Corporation (“NPC”) in the first pharmaceutical products liability suit to go to trial involving the antifungal medicine Lamisil.